某院2016年—2018年间抗糖尿病药物临床使用相关因素分析

Analysis on Relevant Factors of Anti-diabetic Drugs Medication in a Hospital during 2016 to 2018

目的:分析医院2016年—2018年间抗糖尿病药物使用的相关因素,为临床合理用药提供参考。方法:抽取2016年1月—2018年12月间抗糖尿病药物的使用数据,采用Excel 2007版统计软件,分析其抗糖尿病药物的销售金额、构成比、用药频度、日均药品费用。结果:医院2016年—2018年间抗糖尿病药物销售金额逐年增长,且除胰岛素类药物之外,其他降糖药物所占比例超过60%;二甲双胍片、阿卡波糖片、西格列汀片的销售总金额、用药频度居前3位,属于糖尿病患者常用药物。结论:3年间抗糖尿病药物使用情况较为合理,双胍类、α-糖苷酶抑制剂及DDP-4抑制剂类药物市场份额占比较大,可为临床糖尿病患者用药提供了治疗手段。

Objective: To analyze the relevant factors of anti-diabetic drugs medication in a hospital during 2016 to 2018, and to provide a reference for clinical rational drug use. Methods: The data on the use of antidiabetic drugs from January 2016 to December 2018 were extracted, and statistical software Excel 2007 was used to analyze the sales volume, composition ratio, medication frequency and daily drug cost of antidiabetic drugs. Results: During 2016 to 2018, the sale amount of anti-diabetes drugs in the hospital was increased year by year. Besides insulin drugs, other hypoglycemic drugs accounted for more than 60%. The total sales amount and medication frequency of metformin tablets, acarbose tablets and siglitine tablets were in the TOP 3, which were commonly used drugs for patients with diabetes. Conclusion: In the past 3 years, the use of antidiabetic drugs was relatively reasonable, and biguanides, alpha-glycosidase inhibitors and DDP-4 inhibitors accounted for a relatively large market share. Therapeutic means for clinical diabetes patients was provided.